Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breier

Showing results (171-180 of 269) with videos related to

Pageof 27
Sort By:
General Physiology and Biophysics|November 5, 2008
Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivityM Seres, E Poláková, O Krizanová, et al.
Archives of General Psychiatry|October 1, 1994
Neuropsychological impairments in deficit vs nondeficit forms of schizophreniaR W Buchanan, M E Strauss, B Kirkpatrick, et al.
The Journal of Physical Chemistry. A|April 25, 2023
Ro-vibrational Spectrum of Linear Dialuminum Monoxide (Al<sub>2</sub>O) at 10 μmDaniel Witsch, Eileen Döring, Alexander A Breier, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidA R Doran, J Boronow, D R Weinberger, et al.
Pharmacoeconomics|March 3, 2001
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophreniaE T Edgell, S W Andersen, B M Johnstone, et al.
Biological Psychiatry|November 5, 1997
Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamineA K Malhotra, C M Adler, S D Kennison, et al.
The American Journal of Psychiatry|November 1, 1987
Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological functionA Breier, M Albus, D Pickar, et al.
Biological Psychiatry|December 1, 1992
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatientsB Kirkpatrick, W T Carpenter, K Maeda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1994
The effect of clozapine on plasma norepinephrine: relationship to clinical efficacyA Breier, R W Buchanan, R W Waltrip, et al.
Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.
Pageof 27

Showing results (171-180 of 269) with videos related to

Sort By:
Pageof 27
General Physiology and Biophysics|November 5, 2008
Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivityM Seres, E Poláková, O Krizanová, et al.
Archives of General Psychiatry|October 1, 1994
Neuropsychological impairments in deficit vs nondeficit forms of schizophreniaR W Buchanan, M E Strauss, B Kirkpatrick, et al.
The Journal of Physical Chemistry. A|April 25, 2023
Ro-vibrational Spectrum of Linear Dialuminum Monoxide (Al<sub>2</sub>O) at 10 μmDaniel Witsch, Eileen Döring, Alexander A Breier, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidA R Doran, J Boronow, D R Weinberger, et al.
Pharmacoeconomics|March 3, 2001
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophreniaE T Edgell, S W Andersen, B M Johnstone, et al.
Biological Psychiatry|November 5, 1997
Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamineA K Malhotra, C M Adler, S D Kennison, et al.
The American Journal of Psychiatry|November 1, 1987
Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological functionA Breier, M Albus, D Pickar, et al.
Biological Psychiatry|December 1, 1992
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatientsB Kirkpatrick, W T Carpenter, K Maeda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1994
The effect of clozapine on plasma norepinephrine: relationship to clinical efficacyA Breier, R W Buchanan, R W Waltrip, et al.
Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.
Pageof 27